Your browser doesn't support javascript.
loading
Identifying ligands for the PHD1 finger of KDM5A through high-throughput screening.
Ortiz, Gloria; Longbotham, James E; Qin, Sophia L; Zhang, Meng Yao; Lee, Gregory M; Neitz, R Jeffrey; Kelly, Mark J S; Arkin, Michelle R; Fujimori, Danica Galonic.
Afiliación
  • Ortiz G; Department of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
  • Longbotham JE; Department of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
  • Qin SL; Department of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
  • Zhang MY; Department of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
  • Lee GM; Small Molecule Discovery Center (SMDC), University of California San Francisco San Francisco CA 94158 USA.
  • Neitz RJ; Department of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
  • Kelly MJS; Small Molecule Discovery Center (SMDC), University of California San Francisco San Francisco CA 94158 USA.
  • Arkin MR; Department of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
  • Fujimori DG; Department of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
RSC Chem Biol ; 5(3): 209-215, 2024 Mar 06.
Article en En | MEDLINE | ID: mdl-38456036
ABSTRACT
PHD fingers are a type of chromatin reader that primarily recognize chromatin as a function of lysine methylation state. Dysregulated PHD fingers are implicated in various human diseases, including acute myeloid leukemia. Targeting PHD fingers with small molecules is considered challenging as their histone tail binding pockets are often shallow and surface-exposed. The KDM5A PHD1 finger regulates the catalytic activity of KDM5A, an epigenetic enzyme often misregulated in cancers. To identify ligands that disrupt the PHD1-histone peptide interaction, we conducted a high-throughput screen and validated hits by orthogonal methods. We further elucidated structure-activity relationships in two classes of compounds to identify features important for binding. Our investigation offers a starting point for further optimization of small molecule PHD1 ligands.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: RSC Chem Biol Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: RSC Chem Biol Año: 2024 Tipo del documento: Article